首页> 外文OA文献 >Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets
【2h】

Preparation of Coated Valproic Acid and Sodium Valproate Sustained-release Matrix Tablets

机译:丙戊酸和丙戊酸钠缓释基质片剂的制备

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this research was to investigate the technique for preparation of coated valproic acid and sodium valproate sustained-release matrix tablets. Different diluents were tested and selected as the effective absorbent for oily valproic acid. Effect of the amount of absorbent and hydroxypropylmethylcellulose on drug release from valproic acid-sodium valproate matrix tablets prepared with wet granulation technique was evaluated in pH change system. Colloidal silicon dioxide effectively adsorbed liquid valproic acid during wet granulation and granule preparation. The amounts of colloidal silicon dioxide and hydroxypropylmethylcellulose employed in tablet formulations affected drug release from the tablets. The drug release was prominently sustained for over 12 h using hydroxypropylmethylcellulose-based hydrophilic matrix system. The mechanism of drug release through the matrix polymer was a diffusion control. The drug release profile of the developed matrix tablet was similar to Depakine Chrono®, providing the values of similarity factor (f2) and difference factor (f1) of 85.56 and 2.37, respectively. Eudragit® L 30 D-55 was used as effective subcoating material for core matrix tablets before over coating with hydroxypropylmethylcellulose film with organic base solvent. Drug release profile of coated matrix tablet was almost similar to that of Depakine Chrono®.
机译:这项研究的目的是研究制备包衣的丙戊酸和丙戊酸钠缓释基质片剂的技术。测试了不同的稀释剂,并将其选择为油性丙戊酸的有效吸收剂。在pH变化系统中评价了吸收剂和羟丙基甲基纤维素的量对通过湿法制粒技术制备的丙戊酸-丙戊酸钠基质片剂中药物释放的影响。胶体二氧化硅在湿法制粒和颗粒制备过程中有效吸附了液态丙戊酸。片剂中使用的胶体二氧化硅和羟丙基甲基纤维素的量影响药物从片剂中的释放。使用基于羟丙基甲基纤维素的亲水性基质系统,药物释放显着维持超过12小时。通过基质聚合​​物释放药物的机制是扩散控制。开发的基质片剂的药物释放曲线类似于DepakineChrono®,相似度(f2)和差异度(f1)分别为85.56和2.37。使用L 30 D-55作为核心基质片剂的有效底衣材料,然后用有机基础溶剂在羟丙基甲基纤维素薄膜上进行包衣。包衣基质片剂的药物释放曲线几乎与DepakineChrono®相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号